Vimarsana
Biggest News Aggregation in the World

Page 48 - Solothurn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solothurn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solothurn Today - Breaking & Trending Today

Swiss businessman helps Ukrainian refugees - Vimarsana News

Swiss businessman helps Ukrainian refugees

Swiss entrepreneur Guido Fluri chartered a plane to evacuate Ukrainian refugees.

Biogen, Eisai Amend Collaboration Agreement On Alzheimer's Disease Treatments - Vimarsana News

Biogen, Eisai Amend Collaboration Agreement On Alzheimer's Disease Treatments

WESTON (dpa-AFX) - Biogen Inc. (BIIB) and Eisai Co., Ltd. (ESALY.PK) have amended their existing collaboration agreement on Alzheimer's disease treatments. The collaboration on Aducanumab, the

Biogen and Eisai amend collaboration agreements on Alzheimer's disease treatments Seite 1 - Vimarsana News

Biogen and Eisai amend collaboration agreements on Alzheimer's disease treatments Seite 1

15.03.2022 - Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023Lecanemab collaboration to continue unchanged globallyLecanemab supply agreement to extend to 10 years from ... Seite 1

Biogen and Eisai Amend Collaboration Agreements on Alzheimer's Disease Treatments - Vimarsana News

Biogen and Eisai Amend Collaboration Agreements on Alzheimer's Disease Treatments

- Aducanumab collaboration to convert from Eisai sharing of global profits and losses to a global royalty arrangement, effective January 1, 2023.- Lecanemab collaboration to continue unchanged globally-

Biogen, Eisai Amend Collaboration Agreement On Alzheimer's Disease Treatments - Vimarsana News

Biogen, Eisai Amend Collaboration Agreement On Alzheimer's Disease Treatments

(RTTNews) - Biogen Inc. (BIIB) and Eisai Co., Ltd. (ESALY.PK) have amended their existing collaboration agreement on Alzheimer's disease treatment...